Mortality in Patients with Acute Coronary Syndrome—A Prospective 5-Year Follow-Up Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design, Recruitment and Patient Population
2.2. Coronary Angiography
2.3. Echocardiography
2.4. Statistical Analyses
3. Results
3.1. Study Population
3.2. Non-ST Elevation Myocardial Infarction: Comparisons between 2014 and 2007 Cohorts
3.3. ST Elevation Myocardial Infarction Comparisons between 2014 and 2004 Cohorts
3.4. Primary Outcome: All-Cause Mortality
3.5. Secondary Outcome: Heart Failure Hospitalization and Reinfarction
3.6. Predictors of 5-Year Mortality in NSTEMI and STEMI
4. Discussion
4.1. Non-ST-Elevation Myocardial Infarction
4.2. ST-Elevation Myocardial Infarction
4.3. Clinical Implications
4.4. Study Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Madsen, J.K.; Grande, P.; Saunamaki, K.; Thayssen, P.; Kassis, E.; Eriksen, U.; Rasmussen, K.; Haunso, S.; Nielsen, T.T.; Haghfelt, T.; et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation 1997, 96, 748–755. [Google Scholar] [CrossRef] [PubMed]
- Chan, M.Y.; Sun, J.L.; Newby, L.K.; Shaw, L.K.; Lin, M.; Peterson, E.D.; Califf, R.M.; Kong, D.F.; Roe, M.T. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation 2009, 119, 3110–3117. [Google Scholar] [CrossRef] [PubMed]
- Khera, S.; Kolte, D.; Aronow, W.S.; Palaniswamy, C.; Subramanian, K.S.; Hashim, T.; Mujib, M.; Jain, D.; Paudel, R.; Ahmed, A.; et al. Non-ST-elevation myocardial infarction in the United States: Contemporary trends in incidence, utilization of the early invasive strategy, and in-hospital outcomes. J. Am. Heart Assoc. 2014, 3, e000995. [Google Scholar] [CrossRef] [PubMed]
- Vora, A.N.; Wang, T.Y.; Hellkamp, A.S.; Thomas, L.; Henry, T.D.; Goyal, A.; Roe, M.T. Differences in Short- and Long-Term Outcomes among Older Patients with ST-Elevation Versus Non-ST-Elevation Myocardial Infarction with Angiographically Proven Coronary Artery Disease. Circ. Cardiovasc. Qual. Outcomes 2016, 9, 513–522. [Google Scholar] [CrossRef] [PubMed]
- Ahrens, I.; Averkov, O.; Zuniga, E.C.; Fong, A.Y.Y.; Alhabib, K.F.; Halvorsen, S.; Abdul Kader, M.; Sanz-Ruiz, R.; Welsh, R.; Yan, H.; et al. Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox. Clin. Cardiol. 2019, 42, 1028–1040. [Google Scholar] [CrossRef]
- Puymirat, E.; Simon, T.; Cayla, G.; Cottin, Y.; Elbaz, M.; Coste, P.; Lemesle, G.; Motreff, P.; Popovic, B.; Khalife, K.; et al. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation 2017, 136, 1908–1919. [Google Scholar] [CrossRef]
- Lemkes, J.S.; Janssens, G.N.; van der Hoeven, N.W.; Jewbali, L.S.D.; Dubois, E.A.; Meuwissen, M.M.; Rijpstra, T.A.; Bosker, H.A.; Blans, M.J.; Bleeker, G.B.; et al. Coronary Angiography after Cardiac Arrest without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial. JAMA Cardiol. 2020, 5, 1358–1365. [Google Scholar] [CrossRef]
- Doost Hosseiny, A.; Moloi, S.; Chandrasekhar, J.; Farshid, A. Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI. Open Heart 2016, 3, e000405. [Google Scholar] [CrossRef]
- Melichova, D.; Nguyen, T.M.; Salte, I.M.; Klaeboe, L.G.; Sjoli, B.; Karlsen, S.; Dahlslett, T.; Leren, I.S.; Edvardsen, T.; Brunvand, H.; et al. Strain echocardiography improves prediction of arrhythmic events in ischemic and non-ischemic dilated cardiomyopathy. Int. J. Cardiol. 2021, 342, 56–62. [Google Scholar] [CrossRef]
- Grenne, B.; Eek, C.; Sjoli, B.; Dahlslett, T.; Uchto, M.; Hol, P.K.; Skulstad, H.; Smiseth, O.A.; Edvardsen, T.; Brunvand, H. Acute coronary occlusion in non-ST-elevation acute coronary syndrome: Outcome and early identification by strain echocardiography. Heart 2010, 96, 1550–1556. [Google Scholar] [CrossRef]
- Sjoli, B.; Orn, S.; Grenne, B.; Ihlen, H.; Edvardsen, T.; Brunvand, H. Diagnostic capability and reproducibility of strain by Doppler and by speckle tracking in patients with acute myocardial infarction. JACC Cardiovasc. Imaging 2009, 2, 24–33. [Google Scholar] [CrossRef] [PubMed]
- Ibanez, B.; James, S.; Agewall, S.; Antunes, M.J.; Bucciarelli-Ducci, C.; Bueno, H.; Caforio, A.L.P.; Crea, F.; Goudevenos, J.A.; Halvorsen, S.; et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2018, 39, 119–177. [Google Scholar] [CrossRef]
- Collet, J.P.; Thiele, H.; Barbato, E.; Barthelemy, O.; Bauersachs, J.; Bhatt, D.L.; Dendale, P.; Dorobantu, M.; Edvardsen, T.; Folliguet, T.; et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 2020, 42, 1289–1367. [Google Scholar] [CrossRef] [PubMed]
- Lawton, J.S.; Tamis-Holland, J.E.; Bangalore, S.; Bates, E.R.; Beckie, T.M.; Bischoff, J.M.; Bittl, J.A.; Cohen, M.G.; DiMaio, J.M.; Don, C.W.; et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022, 145, e18–e114. [Google Scholar] [CrossRef] [PubMed]
- Vahanian, A.; Beyersdorf, F.; Praz, F.; Milojevic, M.; Baldus, S.; Bauersachs, J.; Capodanno, D.; Conradi, L.; De Bonis, M.; De Paulis, R.; et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev. Esp. Cardiol. 2022, 75, 524. [Google Scholar] [CrossRef] [PubMed]
- Hamm, C.W.; Bassand, J.P.; Agewall, S.; Bax, J.; Boersma, E.; Bueno, H.; Caso, P.; Dudek, D.; Gielen, S.; Huber, K.; et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2011, 32, 2999–3054. [Google Scholar] [CrossRef]
- Roffi, M.; Patrono, C.; Collet, J.P.; Mueller, C.; Valgimigli, M.; Andreotti, F.; Bax, J.J.; Borger, M.A.; Brotons, C.; Chew, D.P.; et al. 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev. Esp. Cardiol. 2015, 68, 1125. [Google Scholar] [CrossRef]
- Fox, K.A.; Clayton, T.C.; Damman, P.; Pocock, S.J.; de Winter, R.J.; Tijssen, J.G.; Lagerqvist, B.; Wallentin, L.; Collaboration, F.I.R. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J. Am. Coll. Cardiol. 2010, 55, 2435–2445. [Google Scholar] [CrossRef]
- Muller, U.M.; Eitel, I.; Eckrich, K.; Erbs, S.; Linke, A.; Mobius-Winkler, S.; Mende, M.; Schuler, G.C.; Thiele, H. Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: An analysis over an 8-year period in a tertiary care centre. Clin. Res. Cardiol. 2011, 100, 297–309. [Google Scholar] [CrossRef]
- Wang, Y.; Zhu, S.; Du, R.; Zhou, J.; Chen, Y.; Zhang, Q. Impact of gender on short-term and long-term all-cause mortality in patients with non-ST-segment elevation acute coronary syndromes: A meta-analysis. Intern. Emerg. Med. 2018, 13, 273–285. [Google Scholar] [CrossRef]
- Khan, A.R.; Golwala, H.; Tripathi, A.; Bin Abdulhak, A.A.; Bavishi, C.; Riaz, H.; Mallipedi, V.; Pandey, A.; Bhatt, D.L. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: A systematic review and meta-analysis. Eur. Heart J. 2017, 38, 3082–3089. [Google Scholar] [CrossRef]
- Bahrmann, P.; Rach, J.; Desch, S.; Schuler, G.C.; Thiele, H. Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy. Clin. Res. Cardiol. 2011, 100, 457–467. [Google Scholar] [CrossRef] [PubMed]
- Kim, M.C.; Ahn, Y.; Rhew, S.H.; Jeong, M.H.; Kim, J.H.; Hong, Y.J.; Chae, S.C.; Kim, Y.J.; Hur, S.H.; Seong, I.W.; et al. Impact of total occlusion of an infarct-related artery on long-term mortality in acute non-ST-elevation myocardial infarction patients who underwent early percutaneous coronary intervention. Int. Heart J. 2012, 53, 160–164. [Google Scholar] [CrossRef] [PubMed]
- Kofoed, K.F.; Kelbaek, H.; Hansen, P.R.; Torp-Pedersen, C.; Hofsten, D.; Klovgaard, L.; Holmvang, L.; Helqvist, S.; Jorgensen, E.; Galatius, S.; et al. Early Versus Standard Care Invasive Examination and Treatment of Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. Circulation 2018, 138, 2741–2750. [Google Scholar] [CrossRef] [PubMed]
- Lopez-Sendon, J.; Swedberg, K.; McMurray, J.; Tamargo, J.; Maggioni, A.P.; Dargie, H.; Tendera, M.; Waagstein, F.; Kjekshus, J.; Lechat, P.; et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur. Heart J. 2004, 25, 1454–1470. [Google Scholar] [CrossRef] [PubMed]
- Milosevic, A.; Vasiljevic-Pokrajcic, Z.; Milasinovic, D.; Marinkovic, J.; Vukcevic, V.; Stefanovic, B.; Asanin, M.; Dikic, M.; Stankovic, S.; Stankovic, G. Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients: The RIDDLE-NSTEMI Study. JACC Cardiovasc. Interv. 2016, 9, 541–549. [Google Scholar] [CrossRef]
- Mehta, S.R.; Granger, C.B.; Boden, W.E.; Steg, P.G.; Bassand, J.P.; Faxon, D.P.; Afzal, R.; Chrolavicius, S.; Jolly, S.S.; Widimsky, P.; et al. Early versus delayed invasive intervention in acute coronary syndromes. N. Engl. J. Med. 2009, 360, 2165–2175. [Google Scholar] [CrossRef]
- Miller, A.L.; Dib, C.; Li, L.; Chen, A.Y.; Amsterdam, E.; Funk, M.; Saucedo, J.F.; Wang, T.Y. Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use. Circ. Cardiovasc. Qual. Outcomes 2012, 5, 662–671. [Google Scholar] [CrossRef]
- Nunez-Gil, I.J.; Garcia-Rubira, J.C.; Luaces, M.; Vivas, D.; De Agustin, J.A.; Gonzalez-Ferrer, J.J.; Bordes, S.; Macaya, C.; Fernandez-Ortiz, A. Mild heart failure is a mortality marker after a non-ST-segment acute myocardial infarction. Eur. J. Intern. Med. 2010, 21, 439–443. [Google Scholar] [CrossRef]
- Byrne, R.A.; Rossello, X.; Coughlan, J.J.; Barbato, E.; Berry, C.; Chieffo, A.; Claeys, M.J.; Dan, G.A.; Dweck, M.R.; Galbraith, M.; et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur. Heart J. Acute Cardiovasc. Care 2023, 44, 3720–3826. [Google Scholar] [CrossRef]
- Obata, J.E.; Horikoshi, T.; Nakamura, T.; Kugiyama, K. Sustained endothelial dysfunction in the infarct-related coronary artery is associated with left ventricular adverse remodeling in survivors of ST-segment elevation myocardial infarction. J. Cardiol. 2020, 75, 261–269. [Google Scholar] [CrossRef] [PubMed]
- de Lemos, J.A.; Morrow, D.A.; Bentley, J.H.; Omland, T.; Sabatine, M.S.; McCabe, C.H.; Hall, C.; Cannon, C.P.; Braunwald, E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med. 2001, 345, 1014–1021. [Google Scholar] [CrossRef]
- Qin, Z.; Du, Y.; Zhou, Q.; Lu, X.; Luo, L.; Zhang, Z.; Guo, N.; Ge, L. NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study. Cardiol. Res. Pract. 2021, 2021, 9943668. [Google Scholar] [CrossRef] [PubMed]
- Kvakkestad, K.M.; Abdelnoor, M.; Claussen, P.A.; Eritsland, J.; Fossum, E.; Halvorsen, S. Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study. Eur. Heart J. Acute Cardiovasc. Care 2016, 5, 243–252. [Google Scholar] [CrossRef]
- Elsman, P.; van ‘t Hof, A.W.; de Boer, M.J.; Suryapranata, H.; Borm, G.F.; Hoorntje, J.C.; Ottervanger, J.P.; Gosselink, A.T.; Dambrink, J.H.; Zijlstra, F. Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention. Am. Heart J. 2006, 151, 1239.e9–1239.e14. [Google Scholar] [CrossRef] [PubMed]
- Kuno, T.; Miyamoto, Y.; Sawano, M.; Kodaira, M.; Numasawa, Y.; Ueda, I.; Suzuki, M.; Noma, S.; Fukuda, K.; Kohsaka, S. Gender Differences in Long-Term Outcomes of Young Patients Who Underwent Percutaneous Coronary Intervention: Long-Term Outcome Analysis from a Multicenter Registry in Japan. Am. J. Cardiol. 2023, 206, 151–160. [Google Scholar] [CrossRef]
- Kazirod-Wolski, K.; Sielski, J.; Gasior, M.; Bujak, K.; Hawranek, M.; Pyka, L.; Gierlotka, M.; Pawlowski, T.; Siudak, Z. Factors affecting short- and long-term survival of patients with acute coronary syndrome treated invasively using intravascular ultrasound and fractional flow reserve: Analysis of data from the Polish Registry of Acute Coronary Syndromes 2017–2020. Kardiol. Pol. 2023, 81, 265–272. [Google Scholar] [CrossRef]
- Thiele, H.; Zeymer, U.; Neumann, F.J.; Ferenc, M.; Olbrich, H.G.; Hausleiter, J.; Richardt, G.; Hennersdorf, M.; Empen, K.; Fuernau, G.; et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 2012, 367, 1287–1296. [Google Scholar] [CrossRef]
NSTEMI 2014 | NSTEMI 2007 | p-Value | STEMI 2014 | STEMI 2004 | p-Value | |
---|---|---|---|---|---|---|
(n = 234) | (n = 82) | (n = 160) | (n = 63) | |||
Baseline clinical characteristics | ||||||
Age, years | 67 ± 13 | 63 ± 14 | 0.06 | 63 ± 11 | 66 ± 12 | 0.10 |
Age > 65, no (%) | 136 (58) | 37 (45) | 0.04 | 67 (42) | 32 (51) | 0.20 |
Male/female, n:n | 173:61 | 61:21 | 0.50 | 125:35 | 49:14 | 0.50 |
BP, diastolic, mmHg | 77 ± 12 | 71 ± 11 | <0.001 | 76 ± 11 | 74 ± 19 | 0.50 |
BP, systolic, mmHg | 131 ± 19 | 127 ± 15 | 0.90 | 123 ± 17 | 139 ± 25 | <0.001 |
Hypertension, no (%) | 114 (49) | 36 (44) | 0.50 | 65 (41) | 18 (29) | 0.10 |
Diabetes mellitus, no (%) | 36 (16) | 7 (9) | 0.10 | 28 (18) | 4(6) | 0.03 |
CAD history, no (%) | 61 (26) | 10 (12) | 0.009 | 23 (14) | 6 (10) | 0.40 |
Troponin T, ng/L (IQR) | 508 (180–1523) | 830 (240–2385) | 0.10 | 3399 (1343–7165) | 4990 (1535–10,257) | 0.10 |
NT-pro BNP, ng/L (IQR) | 209 (30–239) | 337 (62–399) | ||||
Heart rate, bpm | 70 ± 13 | 66 ± 10 | 0.004 | 73 ± 11 | 74 ± 19 | 0.50 |
Killip classification, II-IV, no(%) | 30 (13) | 6 (7) | 0.10 | 29 (18) | 14 (22) | 0.30 |
GRACE risk score | 109 ± 28 | 104 ± 28 | 0.04 | 118 ± 25 | 121 ± 27 | 0.40 |
Medication | ||||||
Aspirin, no (%) | 224 (97) | 82 (100) | 0.40 | 158 (99) | 58 (95) | 0.07 |
Clopidogrel/Ticagrelor, no (%) | 228 (97) | 82 (100) | 0.40 | 159 (100) | 54 (89) | <0.001 |
B-blockers, no (%) | 173 (76) | 71 (87) | 0.04 | 143 (90) | 58 (95) | 0.30 |
Statins, no (%) | 213 (93) | 81 (99) | 0.05 | 145 (98) | 58 (94) | 0.20 |
ACE or ARBs, no (%) | 95 (43) | 16 (20) | <0.001 | 100 (64) | 41 (67) | 0.80 |
Echocardiography | ||||||
LVEF, % | 49 ± 8 | 49 ± 6 | 0.90 | 46 ± 7 | 45 ± 10 | 0.50 |
LVESV, mL | 70 ± 30 | 69 ± 22 | 0.90 | 68 ± 24 | 58 ± 25 | 0.009 |
LVEDV, mL | 135 ± 39 | 134 ± 31 | 0.90 | 125 ± 36 | 106 ± 32 | <0.001 |
Time to revascularization | ||||||
Symptoms to thrombolysis, hours (IQR) | 2.5 (1.4–3.9) | |||||
Hospitalization to PCI/CABG, hours (IQR) | 14.2 (8.2–22.4) | 21.8 (15.8–37.5) | <0.001 | 0.2 (0.2–0.47) | 25.9 (3.3–29.2) | <0.001 |
Symptoms to coronary angiography, hours (IQR) | 28.2 (18.1–46.3) | 30.3 (18.0–48.3) | 0.20 | 2.8 (2.0–4.8) | 21.7 (5.4–27.1) | <0.001 |
Early revascularization, <24 h (%) | 175 (79) | 49 (60) | <0.001 | 159 (100) | 35 (70) | <0.001 |
NSTEMI 2014 (n = 234) | NSTEMI 2007 (n = 82) | p Value | |
---|---|---|---|
Primary outcome | |||
1-year all-cause mortality, no (%) | 8 (3.5) | 4 (4.9) | 0.50 |
5-year all-cause mortality, no (%) | 26 (11.4) | 12 (14.6) | 0.40 |
Secondary outcome | |||
AMI recurrence, no (%) | 26 (11) | 15 (18) | 0.10 |
Rehospitalization with heart failure, no (%) | 7 (4) | 9 (11) | 0.02 |
Culprit lesion | |||
Stenosis, no (%) | 156 (67) | 51 (62) | 0.50 |
Occluded, no (%) | 78 (33) | 31 (38) | 0.50 |
Left anterior descending artery, no (%) | 99 (42) | 26 (32) | 0.06 |
Circumflex artery, no (%) | 65 (28) | 22 (27) | 0.50 |
Right coronary artery, no (%) | 57 (24) | 24 (29) | 0.40 |
Revascularization | |||
Percutaneous coronary intervention, no (%) | 218 (93) | 69 (84) | 0.02 |
Coronary artery bypass graft, no (%) | 3 (1) | 7 (9) | 0.004 |
No intervention, no (%) | 13 (6) | 6 (7) | 0.60 |
STEMI 2014(n = 160) | STEMI 2004 (n = 63) | p Value | |
---|---|---|---|
Primary outcome | |||
1-year all-cause mortality, no (%) | 2 (1.3) | 7 (11.1) | <0.001 |
5-year all-cause mortality, no (%) | 11 (7.0) | 14 (22.2) | 0.004 |
Secondary outcome | |||
AMI recurrence, no (%) | 6 (4) | 16 (25) | <0.001 |
Rehospitalization with heart failure, no (%) | 1 (1) | 9 (15) | <0.001 |
Culprit lesion | |||
Stenosis, no (%) | 36 (23) | 35 (56) | <0.001 |
Occluded, no (%) | 124 (76) | 25 (40) | <0.001 |
Left anterior descending artery, no (%) | 75 (47) | 34 (54) | 0.20 |
Circumflex artery, no (%) | 19 (12) | 7 (11) | 0.60 |
Right coronary artery, no (%) | 62 (39) | 19 (28) | 0.10 |
Revascularization | |||
Rescue PCI, no (%) | 17 (27) | ||
PCI, no (%) | 157 (98) | 52 (84) | <0.001 |
Coronary artery bypass graft, no (%) | 0 (0) | 5 (8) | 0.002 |
No intervention, no (%) | 3 (2) | 5 (8) | 0.04 |
NSTEMI | STEMI | |||||||
---|---|---|---|---|---|---|---|---|
Univariable HR (95% CI) | p-Value | Multivariable HR (95% CI) | p-Value | Univariable HR (95% CI) | p-Value | Multivariable HR (95% CI) | p-Value | |
Risk factor | ||||||||
Age (per year increment) | 1.11 (1.07–1.15) | <0.001 | 1.09 (1.05–1.13) | <0.001 * | 1.10 (1.06–1.15) | <0.001 | 1.12(1.06–1.19) | <0.001 * |
BMI | 0.90 (0.80–0.97) | 0.01 | 0.94 (0.87–1.04) | 0.20 * | 0.91 (0.80–1.05) | 0.20 | ||
Diabetes mellitus | 1.20 (0.50–2.90) | 0.70 | 1.07 (0.32–3.63) | 0.90 | ||||
Smoker/prior smoker | 0.66 (0.44–0.98) | 0.04 | 0.91 (0.60–1.43) | 0.70 * | ||||
CAD history | 3.30 (1.70–6.30) | <0.001 | 2.08 (1.05–4.10) | 0.03 * | 2.49 (0.88–6.30) | 0.05 | 0.7 (0.13–3.80) | 0.70 * |
Clinical features | ||||||||
GRACE risk score > 140 | 5.65 (2.98–10.73) | <0.001 | 6.26 (2.19–17.91) | <0.001 | 6.27 (2.85–13.81) | <0.001 | 6.61 (2.5–17.47) | <0.001 |
NT-proBNP (per 10-fold increase) | 2.86 (1.49–5.48) | 0.002 | 0.74 (0.29–1.86) | 0.50 | 1.9.30 (4.96–75.12) | <0.001 | 24.70 (2.75–221.2) | 0.004 |
Troponin T (per 10-fold increase) | 1.01 (0.59–1.73) | 0.90 | 5.40 (1.79–16.30) | 0.003 | 4.9 (1.10–21.93) | 0.04 | ||
LVEF | 0.93 (0.90–0.96) | <0.001 | 4.56 (1.54–13.50) | <0.006 | 0.94 (0.90–0.98) | 0.008 | 0.97 (0.92–1.03) | 0.40 |
Heart rate | 1.03 (1.00–1.06) | 0.04 | 1.05 (1.05–1.09) | 0.003 | 1.02 (0.99–1.05) | 0.08 | ||
Hospitalization to PCI, hour (per 10-fold increase) ◊ | 5.60 (1.99–15.74) | <0.001 | 4.03 (1.26–12.89) | 0.02 | 2.34 (1.05–5.24) | 0.04 | 2.12 (1.05–4.28) | 0.04 |
Symptoms to PCI, hour (per 10-fold increase) ◊ | 3.43 (1.32–8.90) | 0.01 | 0.22 (0.655–6.26) | 0.05 ¥ | 2.95 (1.30–6.73) | 0.01 | 2.48 (1.10–5.58) | 0.03 ¥ |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nguyen, T.M.; Melichova, D.; Aabel, E.W.; Lie, Ø.H.; Klæboe, L.G.; Grenne, B.; Sjøli, B.; Brunvand, H.; Haugaa, K.; Edvardsen, T. Mortality in Patients with Acute Coronary Syndrome—A Prospective 5-Year Follow-Up Study. J. Clin. Med. 2023, 12, 6598. https://doi.org/10.3390/jcm12206598
Nguyen TM, Melichova D, Aabel EW, Lie ØH, Klæboe LG, Grenne B, Sjøli B, Brunvand H, Haugaa K, Edvardsen T. Mortality in Patients with Acute Coronary Syndrome—A Prospective 5-Year Follow-Up Study. Journal of Clinical Medicine. 2023; 12(20):6598. https://doi.org/10.3390/jcm12206598
Chicago/Turabian StyleNguyen, Thuy Mi, Daniela Melichova, Eivind W. Aabel, Øyvind H. Lie, Lars Gunnar Klæboe, Bjørnar Grenne, Benthe Sjøli, Harald Brunvand, Kristina Haugaa, and Thor Edvardsen. 2023. "Mortality in Patients with Acute Coronary Syndrome—A Prospective 5-Year Follow-Up Study" Journal of Clinical Medicine 12, no. 20: 6598. https://doi.org/10.3390/jcm12206598
APA StyleNguyen, T. M., Melichova, D., Aabel, E. W., Lie, Ø. H., Klæboe, L. G., Grenne, B., Sjøli, B., Brunvand, H., Haugaa, K., & Edvardsen, T. (2023). Mortality in Patients with Acute Coronary Syndrome—A Prospective 5-Year Follow-Up Study. Journal of Clinical Medicine, 12(20), 6598. https://doi.org/10.3390/jcm12206598